X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3536) 3536
Publication (463) 463
Book Review (34) 34
Book Chapter (24) 24
Dissertation (9) 9
Trade Publication Article (4) 4
Conference Proceeding (3) 3
Magazine Article (3) 3
Reference (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2380) 2380
animals (1678) 1678
male (1666) 1666
humans (1457) 1457
obesity (1381) 1381
high-fat diet (1195) 1195
diet (1061) 1061
nutrition & dietetics (869) 869
female (805) 805
rats (756) 756
high fat diet (740) 740
mice (739) 739
metabolism (726) 726
endocrinology & metabolism (641) 641
glucose (617) 617
insulin (591) 591
adult (587) 587
physiological aspects (581) 581
diet, high-fat (570) 570
body weight (561) 561
insulin resistance (535) 535
rodents (535) 535
insulin-resistance (513) 513
diet, high-fat - adverse effects (465) 465
diabetes (462) 462
inflammation (451) 451
lipids (404) 404
article (400) 400
physiology (391) 391
oxidative stress (389) 389
food-intake (382) 382
research (379) 379
middle aged (369) 369
obesity - metabolism (364) 364
analysis (359) 359
fatty acids (354) 354
health aspects (351) 351
high-fat (351) 351
gene expression (347) 347
dietary fats - administration & dosage (335) 335
nutrition (332) 332
food (327) 327
metabolic syndrome (326) 326
mice, inbred c57bl (325) 325
liver (319) 319
biochemistry & molecular biology (307) 307
cholesterol (304) 304
proteins (304) 304
high-fat meal (302) 302
neurosciences (296) 296
blood glucose - metabolism (292) 292
risk factors (287) 287
triglycerides - blood (282) 282
rats, sprague-dawley (278) 278
insulin - blood (272) 272
medicine (270) 270
pharmacology & pharmacy (266) 266
energy intake (260) 260
leptin (260) 260
triglycerides (253) 253
type 2 diabetes (252) 252
liver - metabolism (248) 248
research article (247) 247
food intake (244) 244
dextrose (241) 241
diabetes mellitus (239) 239
adipose-tissue (237) 237
postprandial period (235) 235
body-weight (234) 234
multidisciplinary sciences (233) 233
obesity - etiology (232) 232
lipid metabolism (229) 229
homeostasis (226) 226
disease models, animal (225) 225
digestive, oral, and skin physiology (219) 219
carbohydrates (213) 213
young adult (213) 213
metabolic disorders (210) 210
exercise (208) 208
obesity - physiopathology (207) 207
behavioral sciences (203) 203
studies (201) 201
adipose tissue (200) 200
dietary supplements (199) 199
time factors (197) 197
energy metabolism (194) 194
weight-loss (193) 193
expression (192) 192
gene-expression (191) 191
food science & technology (187) 187
cross-over studies (186) 186
glucagon-like peptide-1 (186) 186
rats, wistar (186) 186
science (186) 186
glucose metabolism (176) 176
diet-induced obesity (175) 175
meals (173) 173
nutrition research (173) 173
body weight - drug effects (170) 170
appetite (162) 162
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3540) 3540
Japanese (8) 8
French (4) 4
Korean (4) 4
Spanish (3) 3
Chinese (2) 2
Catalan (1) 1
Croatian (1) 1
German (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Nutrients, ISSN 2072-6643, 01/2019, Volume 11, Issue 1, p. 157
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 11/2013, Volume 15, Issue 11, pp. 1040 - 1048
Aims Postprandial triglyceridaemia is a risk factor for cardiovascular disease (CVD). This study investigated the effects of steady‐state liraglutide 1.8 mg... 
antidiabetic drug | lipid‐lowering therapy | GLP‐1 analogue | phase I‐II study | type II diabetes | randomized trial | Type II diabetes | Randomized trial | Antidiabetic drug | Lipid-lowering therapy | GLP-1 analogue | Phase I-II study | LIPEMIA | OXIDATIVE STRESS | RECEPTOR AGONISTS | EXENATIDE | ACID BREATH TEST | INSULIN RESPONSES | MELLITUS | lipid-lowering therapy | phase I-II study | THERAPY | GLUCOSE | ENDOCRINOLOGY & METABOLISM | GLUCAGON | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Diet, High-Fat - adverse effects | Half-Life | Glucagon-Like Peptide 1 - blood | Male | Hypoglycemic Agents - blood | Cardiovascular Diseases - complications | Hypolipidemic Agents - blood | Lipids - blood | Postprandial Period | Cardiovascular Diseases - epidemiology | Female | Glucagon-Like Peptide 1 - pharmacokinetics | Diabetes Mellitus, Type 2 - complications | Hyperlipidemias - complications | Body Mass Index | Hypoglycemic Agents - therapeutic use | Hypolipidemic Agents - adverse effects | Hypoglycemic Agents - pharmacokinetics | Double-Blind Method | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Risk Factors | Hyperlipidemias - prevention & control | Germany - epidemiology | Cross-Over Studies | Diabetes Mellitus, Type 2 - blood | Gastric Emptying - drug effects | Hyperlipidemias - etiology | Denmark - epidemiology | Aged | Hypolipidemic Agents - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypolipidemic Agents - pharmacokinetics | Hypoglycemic Agents - adverse effects | Liraglutide | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Low density lipoproteins | Anticholesteremic agents | Clinical trials | Triglycerides | Glucose | Fatty acids | Cholesterol | Dextrose | Glucose metabolism | Hypoglycemic agents | Diabetes therapy | Lipids | Diet | Apolipoproteins
Journal Article